Zobrazeno 1 - 10
of 269
pro vyhledávání: '"C, Regamey"'
Publikováno v:
Clinical Infectious Diseases. 26:1312-1320
The objective of this randomized, double-blind, multicenter study of 329 adult patients requiring hospitalization was to compare the safety and efficacy of sparfloxacin at a dosage of 200 mg once daily (following a 400-mg loading dose on day 1) with
Publikováno v:
Chemotherapy. 41:306-315
We conducted a prospective, randomized, multicentric study in community hospitals. Patients with clinical sepsis, rectal temperature > or = 38 degrees C and pulse rate > or = 100 bpm were randomized to receive ceftazidime (group CAZ) or a combination
Autor:
P. Stadler, E. Hecker, E. Descombes, G. Schrago, C. Chizzolini, P. Dele´aval, C. Regamey, P. Pugin, A. Nicole
Publikováno v:
Clinical Rheumatology. 20:290-292
Polyarteritis nodosa (PAN) is a rare vasculitis associated with hepatitis B virus (HBV) infection in a significant proportion of cases. When used to treat HBV-related PAN, immunosuppressive agents may enhance viral replication and relaspes are freque
Publikováno v:
Revue medicale suisse. 1(36)
Blood culture negative endocarditis (BCNE) account for about 5% of all cases of endocarditis. Diagnosis and initiation of antimicrobial therapy may be delayed, with a negative impact on clinical outcome. The most common cause of BCNE is antimicrobial
Publikováno v:
Revue medicale de la Suisse romande. 121(8)
Publikováno v:
Revue medicale de la Suisse romande. 121(8)
Publikováno v:
Revue medicale de la Suisse romande. 121(8)
Publikováno v:
Schweizerische medizinische Wochenschrift. 130(10)
The influenza vaccine was underused in Switzerland in 1996, as less than half of people at risk for the disease were vaccinated. We performed this study in 1997 to determine (1) the immunisation rate in the patients admitted to the internal medicine
Publikováno v:
Revue medicale de la Suisse romande. 120(1)
Publikováno v:
Revue medicale de la Suisse romande. 120(1)